• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Judge OKs $2.6M Olympus shareholder settlement

Judge OKs $2.6M Olympus shareholder settlement

February 5, 2014 By Brad Perriello

Judge OKs $2.6M Olympus shareholder lawsuit settlement

A shareholder’s lawsuit filed against Olympus (PINK:OCPNY) over a $1.7 billion accounting scandal is slated for a $2.6 million settlement after a federal judge granted preliminary approval to the deal last week.

Lloyd Graham sued Olympus in November 2011, a month after Olympus sacked its 1st non-Japanese CEO just 2 weeks into his tenure. The ex-CEO, Michael Woodford, had questioned a $687 million fee Olympus paid to an acquisitions consultant.

Olympus later admitted to channeling money through investment funds to hide heavy losses, revealing that nearly $1.7 billion in possibly illegal payments were used to conceal losses on investments over the last 2 decades. Investors reacted to the scandal by slashing some 50% from Olympus stock.

The Graham lawsuit aims to cover anyone who bought Olympus stock between Nov. 7, 2006, and Nov. 7, 2011, according to court documents. A $2.6 million deal was struck Sept. 26, 2013, between the purported class action plaintiffs and the Japanese tech giant, according to the documents.

Although Olympus continues to deny any wrongdoing related to the lawsuit’s allegations, it "concluded that further conduct of the litigation would be protracted and expensive, and that it is desirable that the litigation be fully and finally settled," according to the documents.

Judge Jeffrey Schmehl of the U.S. District Court for Eastern Pennsylvania granted preliminary approval to the settlement Jan. 28, court records show.

Woodford, the company’s first non-Japanese CEO, was sacked after questioning the $687 million acquisition consulting fee just 2 weeks into the job. He resigned from Olympus’ board after the massive accounting scandal broke. The Graham lawsuit originally named Woodford as a defendant, but he was dismissed from the case in January 2013, the records show.

Filed Under: Legal News, News Well, Wall Street Beat Tagged With: Olympus

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy